These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22444244)

  • 1. Adaptive radiotherapy for long course neo-adjuvant treatment of rectal cancer.
    Nijkamp J; Marijnen C; van Herk M; van Triest B; Sonke JJ
    Radiother Oncol; 2012 Jun; 103(3):353-9. PubMed ID: 22444244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeat CT assessed CTV variation and PTV margins for short- and long-course pre-operative RT of rectal cancer.
    Nijkamp J; Swellengrebel M; Hollmann B; de Jong R; Marijnen C; van Vliet-Vroegindeweij C; van Triest B; van Herk M; Sonke JJ
    Radiother Oncol; 2012 Mar; 102(3):399-405. PubMed ID: 22239865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Margin and PTV volume reduction using a population based library of plans strategy for rectal cancer radiotherapy.
    Beekman C; van Triest B; van Beek S; Sonke JJ; Remeijer P
    Med Phys; 2018 Oct; 45(10):4345-4354. PubMed ID: 30129043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individualized nonadaptive and online-adaptive intensity-modulated radiotherapy treatment strategies for cervical cancer patients based on pretreatment acquired variable bladder filling computed tomography scans.
    Bondar ML; Hoogeman MS; Mens JW; Quint S; Ahmad R; Dhawtal G; Heijmen BJ
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1617-23. PubMed ID: 22270164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative helical tomotherapy and megavoltage computed tomography for rectal cancer: impact on the irradiated volume of small bowel.
    Engels B; De Ridder M; Tournel K; Sermeus A; De Coninck P; Verellen D; Storme GA
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1476-80. PubMed ID: 19231097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anatomic variations due to radical prostatectomy. Impact on target volume definition and dose-volume parameters of rectum and bladder.
    Sanguineti G; Castellone P; Foppiano F; Franzone P; Marcenaro M; Tognoni P; Bolognesi A; Ceresoli GL; Fiorino C
    Strahlenther Onkol; 2004 Sep; 180(9):563-72. PubMed ID: 15378187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 1.5 T transverse magnetic field in radiotherapy of rectal cancer: Impact on the dose distribution.
    Uilkema S; van der Heide U; Sonke JJ; Moreau M; van Triest B; Nijkamp J
    Med Phys; 2015 Dec; 42(12):7182-9. PubMed ID: 26632072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A margin-of-the-day online adaptive intensity-modulated radiotherapy strategy for cervical cancer provides superior treatment accuracy compared to clinically recommended margins: a dosimetric evaluation.
    Ahmad R; Bondar L; Voet P; Mens JW; Quint S; Dhawtal G; Heijmen B; Hoogeman M
    Acta Oncol; 2013 Oct; 52(7):1430-6. PubMed ID: 23902275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
    Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
    Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
    Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential dosimetric benefit of an adaptive plan selection strategy for short-course radiotherapy in rectal cancer patients.
    Lutkenhaus LJ; de Jong R; Geijsen ED; Visser J; van Wieringen N; Bel A
    Radiother Oncol; 2016 Jun; 119(3):525-30. PubMed ID: 27130729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for online organ motion correction for intensity-modulated radiotherapy of prostate cancer: prostate, rectum, and bladder dose effects.
    Rijkhorst EJ; Lakeman A; Nijkamp J; de Bois J; van Herk M; Lebesque JV; Sonke JJ
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1254-60. PubMed ID: 19857789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Online adaptive radiotherapy compared to plan selection for rectal cancer: quantifying the benefit.
    de Jong R; Crama KF; Visser J; van Wieringen N; Wiersma J; Geijsen ED; Bel A
    Radiat Oncol; 2020 Jul; 15(1):162. PubMed ID: 32641080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT-guided intensity-modulated radiotherapy for bladder cancer: isocentre shifts, margins and their impact on target dose.
    Redpath AT; Muren LP
    Radiother Oncol; 2006 Dec; 81(3):276-83. PubMed ID: 17113669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric benefit of an adaptive treatment by means of plan selection for rectal cancer patients in both short and long course radiation therapy.
    de Jong R; Visser J; Crama KF; van Wieringen N; Wiersma J; Geijsen ED; Bel A
    Radiat Oncol; 2020 Jan; 15(1):13. PubMed ID: 31931829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of rectal motion during neo-adjuvant radiochemotherapy for rectal cancer with image-guided tomotherapy: implications for adaptive dose escalation strategies.
    Maggiulli E; Fiorino C; Passoni P; Broggi S; Gianolini S; Salvetti C; Slim N; Di Muzio NG; Calandrino R
    Acta Oncol; 2012 Mar; 51(3):318-24. PubMed ID: 22497434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive radiotherapy in muscle invasive urinary bladder cancer--an effective method to reduce the irradiated bowel volume.
    Tuomikoski L; Collan J; Keyriläinen J; Visapää H; Saarilahti K; Tenhunen M
    Radiother Oncol; 2011 Apr; 99(1):61-6. PubMed ID: 21429607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The variability of the clinical target volume for rectal cancer due to internal organ motion during adjuvant treatment.
    Nuyttens JJ; Robertson JM; Yan D; Martinez A
    Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):497-503. PubMed ID: 12023155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of mesorectum motion in determining PTV margins in rectal cancer patients treated with neoadjuvant radiotherapy.
    Alickikus ZA; Kuru A; Aydin B; Akcay D; Gorken IB
    J Radiat Res; 2020 Mar; 61(2):335-342. PubMed ID: 31867610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
    Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.